EUVIMEDEUVIMED entdecken
Crossref

Carvedilol inhibits neuronal hyperexcitability caused by epilepsy‐associated KCNT1 mutations

Chang Di, Tong Wu, Kai Gao, Na Li, Huifang Song, Lili Wang, Haojie Sun, Jingyun Yi, Xinran Zhang, Jiexin Chen, Mala Shah, Yuwu Jiang und 1 weitere

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.17360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Chang Di und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking Un…. Hauptthemen laut MEDLINE: Potassium Channels, Sodium-Activated, Epilepsy, Mutation, Carvedilol. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China Grant, Key Project of Clinical Medicine Research of National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical Univers…, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose KCNT1 encodes a sodium‐activated potassium channel (Slack channel), and its mutation can cause several forms of epilepsy. Traditional antiepileptic medications have limited efficacy in treating patients with KCNT1 mutations. Here, we describe one heterozygous KCNT1 mutation, M267T, in a patient with EIMFS. The pathological channel properties of this mutation and its effect on neuronal excitability were investigated. Additionally, this study aimed to develop a medication for effective prevention of KCNT1 mutation‐induced seizures. Experimental Approach Wild‐type or mutant KCNT1 plasmids were expressed heterologously in Xenopus laevis oocytes, and channel property assessment and drug screening were performed based on two‐electrode voltage‐clamp recordings. The single‐channel properties were investigated using the excised inside‐out patches from HEK293T cells. Through in utero electroporation, WT and M267T Slack channels were expressed in the hippocampal CA1 pyramidal neurons in male mice, followed by the examination of the electrical properties using the whole‐cell current‐clamp technique. The kainic acid‐induced epilepsy model in male mice was used to evalute the antiseizure effects of carvedilol. Key Results The KCNT1 M267T mutation enhanced Slack channel function by increasing single‐channel open probability. Through screening 16 FDA‐approved ion channel blockers, we found that carvedilol effectively reversed the mutation‐induced gain‐of‐function channel properties. Notably, the KCNT1 M267T mutation in the mouse hippocampal CA1 pyramidal neurons affected afterhyperpolarization properties and induced neuronal hyperexcitability, which was inhibited by carvedilol. Additionally, carvedilol exhibited antiseizure effects in the kainic acid‐induced epilepsy model. Conclusion and Implication Our findings suggest carvedilol as a new potential candidate for treatment of epilepsies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Potassium Channels, Sodium-ActivatedEpilepsyMutationCarvedilolAnticonvulsantsAnimalsHumansMiceMaleHEK293 CellsNerve Tissue ProteinsNeuronsXenopus laevisFemaleKainic Acid

Stichwörter der Autor:innen

KCNT1afterhyperpolarizationcarvedilolepilepsy

Substanzen

Potassium Channels, Sodium-ActivatedKCNT1 protein, humanCarvedilolAnticonvulsantsNerve Tissue ProteinsKainic Acid

Autor:innen und Institutionen

  • State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China.
  • Department of Pharmacology, School of Basic Medical Sciences, Peking University Health Science Center; State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.
  • Department of Pediatrics, Peking University First Hospital, Beijing, China.
  • Beijing Key Laboratory of Molecular Diagnosis and Study on Pediatric Genetic Diseases, Beijing, China.
  • Children Epilepsy Center, Peking University First Hospital, Beijing, China.
  • Key Laboratory for Neuroscience, Ministry of Education/National Health and Family Planning Commission, Peking University, Beijing, China.

ORCID-Profile: Zhuo Huang

Förderung

  • National Natural Science Foundation of China Grant
  • Key Project of Clinical Medicine Research of National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical Univers…
  • National Key Research and Development Program of China
  • Beijing Natural Science Foundation
  • Chinese National Programs for Brain Science and Brain-like intelligence technology
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Di, C., Wu, T., Gao, K., Li, N., Song, H., Wang, L., Sun, H., Yi, J., Zhang, X., Chen, J., Shah, M., Jiang, Y., & Huang, Z. (2025). Carvedilol inhibits neuronal hyperexcitability caused by epilepsy‐associated KCNT1 mutations. British Journal of Pharmacology. https://doi.org/10.1111/bph.17360

Vancouver

Di C, Wu T, Gao K, Li N, Song H, Wang L, et al. Carvedilol inhibits neuronal hyperexcitability caused by epilepsy‐associated KCNT1 mutations. British Journal of Pharmacology. 2025. doi:10.1111/bph.17360

BibTeX
@article{Di2025,
  author = {Di, Chang and Wu, Tong and Gao, Kai and Li, Na and Song, Huifang and Wang, Lili and Sun, Haojie and Yi, Jingyun and Zhang, Xinran and Chen, Jiexin and Shah, Mala and Jiang, Yuwu and Huang, Zhuo},
  title = {Carvedilol inhibits neuronal hyperexcitability caused by epilepsy‐associated KCNT1 mutations},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.17360}
}
Kostenlos starten →